Related Experiment Video
Updated: Jul 11, 2026

IR-TEx: An Open Source Data Integration Tool for Big Data Transcriptomics Designed for the Malaria Vector Anopheles gambiae
Published on: January 15, 2020
Identification of novel glutathione transferases and polymorphic variants by expressed sequence tag database analysis
P G Board1, G Chelvanayagam, L S Jermiin
1John Curtin School of Medical Research, The Australian National University, Canberra, Australian Capital Territory, Australia. Philip.Board@anu.edu.au
Searching the expressed sequence tag (EST) database identified the glutathione S-transferase (GST) Zeta class. A GST Z1 variant shows higher activity, potentially aiding lactic acidosis treatment.
Area of Science:
- Genomics
- Biochemistry
- Pharmacogenetics
Background:
- The expressed sequence tag (EST) database facilitates gene discovery through sequence alignment.
- The glutathione S-transferase (GST) superfamily is crucial for biotransformation and detoxification.
- Identifying novel gene families and allelic variants is essential for understanding genetic diversity.
Framework:
- Utilized sequence alignment strategies to search the human EST database.
- Focused on the glutathione S-transferase (GST) super family for gene discovery.
- Identified the Zeta class of GSTs and their enzymatic functions.
Implementation:
- Characterized the catalytic activity of Zeta class GSTs in alpha-haloacid biotransformation and maleylacetoacetic acid isomerization.
- Discovered allelic variants for GST Z1 and GST A2 genes via EST database analysis.
- Assessed the substrate activity of a specific GST Z1 variant (GST Z1A) with dichloroacetic acid.
Implications:
- The identified Zeta class GSTs play a key role in tyrosine catabolism.
- A specific GST Z1 variant (GST Z1A) exhibits enhanced activity with dichloroacetic acid, suggesting therapeutic potential.
- EST database searching is a valuable method for discovering pharmacogenetically relevant gene families and variants.
Related Concept Videos
Tagging and Fusion Proteins
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

